Skip to the page

Data / Drug companies / Akron Pharma Inc.

Akron Pharma Inc.: 60 products in the FDA NDC directory, labeler code 71399

Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).

Akron Pharma Inc. (labeler code 71399) lists 60 products in the FDA National Drug Code Directory, covering 36 finished drugs by generic name. By type: 48 over the counter drugs, 12 prescription drugs. Its main marketing category is over the counter monograph drugs. The newest product started marketing on September 26, 2025.

The request: Watch Akron Pharma Inc. (FDA labeler code 71399): each new product listing and each discontinued product. $10 of work on sign-up, no card.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
71399
Products in commercial distribution
60
Packages
129
Finished drugs by generic name
36
Prescription products
12
Over the counter products
48
Flagged as original packager
60 of 60 products that carry the flag
Started marketing in the last 12 months
0
Earliest marketing start
December 26, 2014
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Over the counter monograph drugs4676.7%
Other unapproved drugs1118.3%
Generic drugs (ANDA)35%

Products by type

TypeProductsShare
Over the counter drugs4880%
Prescription drugs1220%

Drugs it lists

Finished drugs by generic name, with how many companies list each.

Dosage forms

Dosage formProductsShare
Liquid1626.7%
Cream711.7%
Ointment610%
Suspension58.3%
Patch58.3%
Tablet46.7%
Solution46.7%
Capsule23.3%
Lotion23.3%
Gel23.3%
Tablet, chewable23.3%
Tablet, coated11.7%

Pharmacologic classes

FDA established pharmacologic classes of its products.

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Regular strength antacid peppermint71399-9940Tablet, chewableOver the counter monograph drugsSeptember 26, 2025
Regular Strength Assorted Flavors71399-9939Tablet, chewableOver the counter monograph drugsSeptember 23, 2025
Dibucaine71399-2829OintmentOver the counter monograph drugsJanuary 6, 2025
Hydrocortisone71399-0180CreamOver the counter monograph drugsJanuary 6, 2025
RectoProtect71399-0050CreamOver the counter monograph drugsJanuary 6, 2025
Asper Flex71399-0049CreamOver the counter monograph drugsJanuary 6, 2025
Diphenhydramine HCl71399-1028CapsuleOver the counter monograph drugsDecember 6, 2024
Diphenhydramine HCl71399-1027CapsuleOver the counter monograph drugsDecember 6, 2024
Acetaminophen71399-1026TabletOver the counter monograph drugsDecember 6, 2024
Acetaminophen71399-1025TabletOver the counter monograph drugsDecember 6, 2024
Senna71399-1017TabletOver the counter monograph drugsDecember 6, 2024
Low Dose Aspirin71399-1014Tablet, coatedOver the counter monograph drugsDecember 6, 2024
MICONAZOLE Nitrate 2%71399-0071CreamOver the counter monograph drugsNovember 19, 2024
MEDPURA Benzoyl Peroxide Aqueous Base, Acne Treatment Gel71399-9478GelOver the counter monograph drugsSeptember 13, 2024
MEDPURA Benzoyl Peroxide Aqueous Base, Acne Treatment Gel71399-9474GelOver the counter monograph drugsSeptember 13, 2024
MEDPURA Benzoyl Peroxide71399-9236LiquidOver the counter monograph drugsSeptember 13, 2024
MEDPURA Benzoyl Peroxide71399-9234LiquidOver the counter monograph drugsSeptember 13, 2024
OneLAX71399-8460SuppositoryOver the counter monograph drugsSeptember 13, 2024
Urea Cream 40%71399-8456CreamOther unapproved drugsSeptember 13, 2024
Urea71399-8455LotionOther unapproved drugsSeptember 13, 2024
AsperFlex71399-6854CreamOver the counter monograph drugsSeptember 13, 2024
Hydroseptine71399-6743OintmentOver the counter monograph drugsSeptember 13, 2024
Hydrophor71399-5101OintmentOver the counter monograph drugsSeptember 13, 2024
Vaporx71399-4589OintmentOver the counter monograph drugsSeptember 13, 2024
Sodium sulfacetamide71399-1599ShampooOther unapproved drugsSeptember 13, 2024

CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.